Sangyeul Hwang

Title: Innovations of Sangyeul Hwang in Medical Device Biocompatibility

Introduction

Sangyeul Hwang is an accomplished inventor based in Ann Arbor, Michigan. He is known for his significant contributions to the field of medical devices, particularly in enhancing their biocompatibility. His innovative approach has the potential to improve patient outcomes and advance medical technology.

Latest Patents

Sangyeul Hwang holds a patent for a method of increasing the biocompatibility of medical devices by generating nitric oxide. This patent describes a material that includes a surface and a reactive agent located at the surface of the material. The reactive agent is covalently attached to a backbone of the material and possesses nitrite reductase activity, nitrate reductase activity, and/or nitrosothiol reductase activity. When in contact with blood, the reactive agent converts nitrites, nitrates, and nitrosothiols to nitric oxide. Additionally, a reproducible nitrosothiol sensor is disclosed in this patent.

Career Highlights

Sangyeul Hwang is affiliated with the University of Michigan, where he continues to work on innovative solutions in the medical field. His research focuses on improving the safety and effectiveness of medical devices through advanced materials and biocompatibility techniques.

Collaborations

He has collaborated with notable colleagues, including Mark E. Meyerhoff and Melissa M. Reynolds. Their combined expertise contributes to the advancement of research in medical device technology.

Conclusion

Sangyeul Hwang's work in enhancing the biocompatibility of medical devices through innovative methods showcases his dedication to improving healthcare technology. His contributions are vital for the future of medical device development and patient care.